semaglutide nursing Photo by 3:15 Nurse Monitoring (@315_nurse_monitoring) · May 15, 2026 Ozempic, Wegovy & Breastfeeding: Are

Although semaglutide has not yet been assessed in T1D in clinical trials, retrospective data of off-label use has suggested benefits in reducing HbA1c, weight and insulin requirements 19,20

Gastrointestinal side effects and fluid balance: Nausea : Very common, affecting approximately 20% of patients

Any UK prescriber considering its use must be aware that it would be supplied as an imported unlicensed medicine on a named-patient basis, with full prescriber responsibility

Clinical data show similar overall outcomes at therapeutic doses

Posteriormente, el mdico puede aumentar la dosis a 0,5 mg por semana o ms, segn la respuesta de cada paciente